The makers of Clonazepam Orally Disintegrating Tablets have issued a voluntary recall over mislabeled product packaging.
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Endo has expanded the recall of Clonazepam Orally Disintegrating Tablets (ODT) to include additional lots that may ...
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...